By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, March 17th. Please refresh for updates. First Republic Bank (NYSE:FRC) stock fell 13% with the...
Merck (MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the non-registrational Phase 2 KeyVibe-002 trial. KeyVibe-002...
Merck shares picked up after an upgrade at Wolfe Research. And here is your full Pro Recap of the biggest analyst calls you may have missed on InvestingPro this past week. Start...
Merck stock is down 2% two days after beating on the top and bottom lines. Investors are concerned about full-year guidance which came in below consensus estimates. The company has...
Fed rate decision, Mega-cap tech earnings, U.S. jobs report in focus. Caterpillar shares are a buy amid strong profit and sales growth. Peloton stock set to underperform amid...
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
| Average | 120.81 (+15.95% Upside) |
| High | 155.00 |
| Low | 96.00 |
| Price | 104.19 |
| No. of Analysts | 28 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 192.22 | 199.31 | 188.65 | +1.07 | +0.56% | 143.66M | NASDAQ | |||
| 158.93 | 161.55 | 157.68 | +1.10 | +0.70% | 67.36M | NASDAQ | |||
| 59.92 | 60.39 | 59.72 | -0.13 | -0.22% | 15.47M | NYSE | |||
| 204.28 | 207.88 | 202.15 | +4.47 | +2.24% | 27.20M | NASDAQ | |||
| 105.60 | 106.30 | 104.46 | +2.23 | +2.16% | 40.63M | NASDAQ | |||
| 277.66 | 281.06 | 275.20 | +5.37 | +1.97% | 36.44M | NASDAQ | |||
| 40.18 | 40.50 | 40.00 | +0.17 | +0.42% | 16.95M | NYSE | |||
| 100.28 | 102.43 | 98.67 | +2.70 | +2.77% | 83.99M | NASDAQ | |||
| 98.71 | 101.06 | 97.62 | +0.01 | +0.01% | 57.45M | NASDAQ | |||
| 159.98 | 165.85 | 158.50 | -3.23 | -1.98% | 2.42M | NASDAQ | |||
| 271.91 | 274.99 | 266.90 | +7.23 | +2.73% | 56.31M | NASDAQ | |||
| 8.33 | 8.56 | 8.16 | +0.12 | +1.46% | 22.60M | NYSE | |||
| 106.26 | 107.10 | 105.41 | +2.04 | +1.96% | 31.36M | NASDAQ | |||
| 45.79 | 46.94 | 45.12 | +0.83 | +1.85% | 15.33M | NYSE | |||
| 49.73 | 50.25 | 49.40 | +0.27 | +0.55% | 17.77M | NASDAQ |